Press Release – New York, NY – June 22, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented WallachBeth Capital LLC as the sole placement agent for the recently priced $3.2 million public offering of bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases.
The SRFC team was led by partners Ross Carmel and Jeffrey Wofford, with associate Marissa Johnson.